An Evaluation of BfmR-Regulated Antimicrobial Resistance in the Extensively Drug Resistant (XDR) Acinetobacter baumannii Strain HUMC1

Acinetobacter baumannii is a problematic pathogen due to its common expression of extensive drug resistance (XDR) and ability to survive in the healthcare environment. These characteristics are mediated, in part, by the signal transduction system BfmR/BfmS. We previously demonstrated, in antimicrobi...

Full description

Bibliographic Details
Main Authors: Candace M. Marr, Ulrike MacDonald, Grishma Trivedi, Somnath Chakravorty, Thomas A. Russo
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-10-01
Series:Frontiers in Microbiology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fmicb.2020.595798/full
id doaj-9229fb22507341fead1b8da32e26f34f
record_format Article
spelling doaj-9229fb22507341fead1b8da32e26f34f2020-11-25T03:39:26ZengFrontiers Media S.A.Frontiers in Microbiology1664-302X2020-10-011110.3389/fmicb.2020.595798595798An Evaluation of BfmR-Regulated Antimicrobial Resistance in the Extensively Drug Resistant (XDR) Acinetobacter baumannii Strain HUMC1Candace M. Marr0Candace M. Marr1Ulrike MacDonald2Ulrike MacDonald3Grishma Trivedi4Grishma Trivedi5Somnath Chakravorty6Thomas A. Russo7Thomas A. Russo8Thomas A. Russo9Thomas A. Russo10Department of Medicine, University at Buffalo, Buffalo, NY, United StatesErie County Medical Center, Buffalo, NY, United StatesDepartment of Medicine, University at Buffalo, Buffalo, NY, United StatesVeterans Affairs Western New York Healthcare System, Buffalo, NY, United StatesDepartment of Medicine, University at Buffalo, Buffalo, NY, United StatesVeterans Affairs Western New York Healthcare System, Buffalo, NY, United StatesDepartment of Medicine, University at Buffalo, Buffalo, NY, United StatesDepartment of Medicine, University at Buffalo, Buffalo, NY, United StatesVeterans Affairs Western New York Healthcare System, Buffalo, NY, United StatesDepartment of Microbiology and Immunology, University at Buffalo, Buffalo, NY, United StatesWitebsky Center for Microbial Pathogenesis, University at Buffalo, Buffalo, NY, United StatesAcinetobacter baumannii is a problematic pathogen due to its common expression of extensive drug resistance (XDR) and ability to survive in the healthcare environment. These characteristics are mediated, in part, by the signal transduction system BfmR/BfmS. We previously demonstrated, in antimicrobial sensitive clinical isolates, that BfmR conferred increased resistance to meropenem and polymyxin E. In this study, potential mechanisms were informed, in part, by a prior transcriptome analysis of the antimicrobial sensitive isolate AB307-0294, which identified the porins OprB and aquaporin (Omp33-36, MapA) as plausible mediators for resistance to hydrophilic antimicrobials such as meropenem. Studies were then performed in the XDR isolate HUMC1, since delineating resistance mechanisms in this genomic background would be more translationally relevant. In HUMC1 BfmR likewise increased meropenem and polymyxin E resistance and upregulated gene expression of OprB and aquaporin. However, the comparison of HUMC1 with isogenic mutant constructs demonstrated that neither OprB nor aquaporin affected meropenem resistance; polymyxin E susceptibility was also unaffected. Next, we determined whether BfmR-mediated biofilm production affected either meropenem or polymyxin E susceptibilities. Interestingly, biofilm formation increased resistance to polymyxin E, but had little, if any effect on meropenem activity. Additionally, BfmR mediated meropenem resistance, and perhaps polymyxin E resistance, was due to BfmR regulated factors that do not affect biofilm formation. These findings increase our understanding of the mechanisms by which BfmR mediates intrinsic antimicrobial resistance in a clinically relevant XDR isolate and suggest that the efficacy of different classes of antimicrobials may vary under biofilm inducing conditions.https://www.frontiersin.org/articles/10.3389/fmicb.2020.595798/fullAcinetobacter baumanniimeropenempolymyxin Eextensively drug resistantbiofilmBfmR
collection DOAJ
language English
format Article
sources DOAJ
author Candace M. Marr
Candace M. Marr
Ulrike MacDonald
Ulrike MacDonald
Grishma Trivedi
Grishma Trivedi
Somnath Chakravorty
Thomas A. Russo
Thomas A. Russo
Thomas A. Russo
Thomas A. Russo
spellingShingle Candace M. Marr
Candace M. Marr
Ulrike MacDonald
Ulrike MacDonald
Grishma Trivedi
Grishma Trivedi
Somnath Chakravorty
Thomas A. Russo
Thomas A. Russo
Thomas A. Russo
Thomas A. Russo
An Evaluation of BfmR-Regulated Antimicrobial Resistance in the Extensively Drug Resistant (XDR) Acinetobacter baumannii Strain HUMC1
Frontiers in Microbiology
Acinetobacter baumannii
meropenem
polymyxin E
extensively drug resistant
biofilm
BfmR
author_facet Candace M. Marr
Candace M. Marr
Ulrike MacDonald
Ulrike MacDonald
Grishma Trivedi
Grishma Trivedi
Somnath Chakravorty
Thomas A. Russo
Thomas A. Russo
Thomas A. Russo
Thomas A. Russo
author_sort Candace M. Marr
title An Evaluation of BfmR-Regulated Antimicrobial Resistance in the Extensively Drug Resistant (XDR) Acinetobacter baumannii Strain HUMC1
title_short An Evaluation of BfmR-Regulated Antimicrobial Resistance in the Extensively Drug Resistant (XDR) Acinetobacter baumannii Strain HUMC1
title_full An Evaluation of BfmR-Regulated Antimicrobial Resistance in the Extensively Drug Resistant (XDR) Acinetobacter baumannii Strain HUMC1
title_fullStr An Evaluation of BfmR-Regulated Antimicrobial Resistance in the Extensively Drug Resistant (XDR) Acinetobacter baumannii Strain HUMC1
title_full_unstemmed An Evaluation of BfmR-Regulated Antimicrobial Resistance in the Extensively Drug Resistant (XDR) Acinetobacter baumannii Strain HUMC1
title_sort evaluation of bfmr-regulated antimicrobial resistance in the extensively drug resistant (xdr) acinetobacter baumannii strain humc1
publisher Frontiers Media S.A.
series Frontiers in Microbiology
issn 1664-302X
publishDate 2020-10-01
description Acinetobacter baumannii is a problematic pathogen due to its common expression of extensive drug resistance (XDR) and ability to survive in the healthcare environment. These characteristics are mediated, in part, by the signal transduction system BfmR/BfmS. We previously demonstrated, in antimicrobial sensitive clinical isolates, that BfmR conferred increased resistance to meropenem and polymyxin E. In this study, potential mechanisms were informed, in part, by a prior transcriptome analysis of the antimicrobial sensitive isolate AB307-0294, which identified the porins OprB and aquaporin (Omp33-36, MapA) as plausible mediators for resistance to hydrophilic antimicrobials such as meropenem. Studies were then performed in the XDR isolate HUMC1, since delineating resistance mechanisms in this genomic background would be more translationally relevant. In HUMC1 BfmR likewise increased meropenem and polymyxin E resistance and upregulated gene expression of OprB and aquaporin. However, the comparison of HUMC1 with isogenic mutant constructs demonstrated that neither OprB nor aquaporin affected meropenem resistance; polymyxin E susceptibility was also unaffected. Next, we determined whether BfmR-mediated biofilm production affected either meropenem or polymyxin E susceptibilities. Interestingly, biofilm formation increased resistance to polymyxin E, but had little, if any effect on meropenem activity. Additionally, BfmR mediated meropenem resistance, and perhaps polymyxin E resistance, was due to BfmR regulated factors that do not affect biofilm formation. These findings increase our understanding of the mechanisms by which BfmR mediates intrinsic antimicrobial resistance in a clinically relevant XDR isolate and suggest that the efficacy of different classes of antimicrobials may vary under biofilm inducing conditions.
topic Acinetobacter baumannii
meropenem
polymyxin E
extensively drug resistant
biofilm
BfmR
url https://www.frontiersin.org/articles/10.3389/fmicb.2020.595798/full
work_keys_str_mv AT candacemmarr anevaluationofbfmrregulatedantimicrobialresistanceintheextensivelydrugresistantxdracinetobacterbaumanniistrainhumc1
AT candacemmarr anevaluationofbfmrregulatedantimicrobialresistanceintheextensivelydrugresistantxdracinetobacterbaumanniistrainhumc1
AT ulrikemacdonald anevaluationofbfmrregulatedantimicrobialresistanceintheextensivelydrugresistantxdracinetobacterbaumanniistrainhumc1
AT ulrikemacdonald anevaluationofbfmrregulatedantimicrobialresistanceintheextensivelydrugresistantxdracinetobacterbaumanniistrainhumc1
AT grishmatrivedi anevaluationofbfmrregulatedantimicrobialresistanceintheextensivelydrugresistantxdracinetobacterbaumanniistrainhumc1
AT grishmatrivedi anevaluationofbfmrregulatedantimicrobialresistanceintheextensivelydrugresistantxdracinetobacterbaumanniistrainhumc1
AT somnathchakravorty anevaluationofbfmrregulatedantimicrobialresistanceintheextensivelydrugresistantxdracinetobacterbaumanniistrainhumc1
AT thomasarusso anevaluationofbfmrregulatedantimicrobialresistanceintheextensivelydrugresistantxdracinetobacterbaumanniistrainhumc1
AT thomasarusso anevaluationofbfmrregulatedantimicrobialresistanceintheextensivelydrugresistantxdracinetobacterbaumanniistrainhumc1
AT thomasarusso anevaluationofbfmrregulatedantimicrobialresistanceintheextensivelydrugresistantxdracinetobacterbaumanniistrainhumc1
AT thomasarusso anevaluationofbfmrregulatedantimicrobialresistanceintheextensivelydrugresistantxdracinetobacterbaumanniistrainhumc1
AT candacemmarr evaluationofbfmrregulatedantimicrobialresistanceintheextensivelydrugresistantxdracinetobacterbaumanniistrainhumc1
AT candacemmarr evaluationofbfmrregulatedantimicrobialresistanceintheextensivelydrugresistantxdracinetobacterbaumanniistrainhumc1
AT ulrikemacdonald evaluationofbfmrregulatedantimicrobialresistanceintheextensivelydrugresistantxdracinetobacterbaumanniistrainhumc1
AT ulrikemacdonald evaluationofbfmrregulatedantimicrobialresistanceintheextensivelydrugresistantxdracinetobacterbaumanniistrainhumc1
AT grishmatrivedi evaluationofbfmrregulatedantimicrobialresistanceintheextensivelydrugresistantxdracinetobacterbaumanniistrainhumc1
AT grishmatrivedi evaluationofbfmrregulatedantimicrobialresistanceintheextensivelydrugresistantxdracinetobacterbaumanniistrainhumc1
AT somnathchakravorty evaluationofbfmrregulatedantimicrobialresistanceintheextensivelydrugresistantxdracinetobacterbaumanniistrainhumc1
AT thomasarusso evaluationofbfmrregulatedantimicrobialresistanceintheextensivelydrugresistantxdracinetobacterbaumanniistrainhumc1
AT thomasarusso evaluationofbfmrregulatedantimicrobialresistanceintheextensivelydrugresistantxdracinetobacterbaumanniistrainhumc1
AT thomasarusso evaluationofbfmrregulatedantimicrobialresistanceintheextensivelydrugresistantxdracinetobacterbaumanniistrainhumc1
AT thomasarusso evaluationofbfmrregulatedantimicrobialresistanceintheextensivelydrugresistantxdracinetobacterbaumanniistrainhumc1
_version_ 1724538873801867264